Medical Assistance in Dying in patients with advanced cancer and their caregivers: a mixed methods longitudinal study protocol.
Assisted dying
Cancer
Depression
Desire for hastened death
Distress
Euthanasia
Medical assistance in dying
Medical communication
Palliative care
Will to live
Journal
BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685
Informations de publication
Date de publication:
21 Jul 2021
21 Jul 2021
Historique:
received:
26
11
2020
accepted:
09
06
2021
entrez:
22
7
2021
pubmed:
23
7
2021
medline:
12
10
2021
Statut:
epublish
Résumé
The legal criteria for medical assistance in dying (MAiD) for adults with a grievous and irremediable medical condition were established in Canada in 2016. There has been concern that potentially reversible states of depression or demoralization may contribute to the desire for death (DD) and requests for MAiD. However, little is known about the emergence of the DD in patients, its impact on caregivers, and to what extent supportive care interventions affect the DD and requests for MAiD. The present observational study is designed to determine the prevalence, predictors, and experience of the DD, requests for MAiD and MAiD completion in patients with advanced or metastatic cancer and the impact of these outcomes on their primary caregivers. A cohort of patients with advanced or metastatic solid tumour cancers and their primary caregivers will be recruited from a large tertiary cancer centre in Toronto, Ontario, Canada, to a longitudinal, mixed methods study. Participants will be assessed at baseline for diagnostic information, sociodemographic characteristics, medical history, quality of life, physical and psychological distress, attitudes about the DD and MAiD, communication with physicians, advance care planning, and use of psychosocial and palliative care interventions. Measures will subsequently be completed every six months and at the time of MAiD requests. Quantitative assessments will be supplemented by qualitative interviews in a subset of participants, selected using quota sampling methods. This study has the potential to add importantly to our understanding of the prevalence and determinants of the DD, MAiD requests and completions in patients with advanced or metastatic cancer and of the experience of both patients and caregivers in this circumstance. The findings from this study may also assist healthcare providers in their conversations about MAiD and the DD with patients and caregivers, inform healthcare providers to ensure appropriate access to MAiD, and guide modifications being considered to broaden MAiD legislation and policy.
Sections du résumé
BACKGROUND
BACKGROUND
The legal criteria for medical assistance in dying (MAiD) for adults with a grievous and irremediable medical condition were established in Canada in 2016. There has been concern that potentially reversible states of depression or demoralization may contribute to the desire for death (DD) and requests for MAiD. However, little is known about the emergence of the DD in patients, its impact on caregivers, and to what extent supportive care interventions affect the DD and requests for MAiD. The present observational study is designed to determine the prevalence, predictors, and experience of the DD, requests for MAiD and MAiD completion in patients with advanced or metastatic cancer and the impact of these outcomes on their primary caregivers.
METHODS
METHODS
A cohort of patients with advanced or metastatic solid tumour cancers and their primary caregivers will be recruited from a large tertiary cancer centre in Toronto, Ontario, Canada, to a longitudinal, mixed methods study. Participants will be assessed at baseline for diagnostic information, sociodemographic characteristics, medical history, quality of life, physical and psychological distress, attitudes about the DD and MAiD, communication with physicians, advance care planning, and use of psychosocial and palliative care interventions. Measures will subsequently be completed every six months and at the time of MAiD requests. Quantitative assessments will be supplemented by qualitative interviews in a subset of participants, selected using quota sampling methods.
DISCUSSION
CONCLUSIONS
This study has the potential to add importantly to our understanding of the prevalence and determinants of the DD, MAiD requests and completions in patients with advanced or metastatic cancer and of the experience of both patients and caregivers in this circumstance. The findings from this study may also assist healthcare providers in their conversations about MAiD and the DD with patients and caregivers, inform healthcare providers to ensure appropriate access to MAiD, and guide modifications being considered to broaden MAiD legislation and policy.
Identifiants
pubmed: 34289838
doi: 10.1186/s12904-021-00793-4
pii: 10.1186/s12904-021-00793-4
pmc: PMC8296526
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117Subventions
Organisme : Canadian Institutes of Health Research (CA)
ID : 401506
Organisme : CIHR
ID : 171271
Pays : Canada
Informations de copyright
© 2021. The Author(s).
Références
J Pediatr Hematol Oncol. 2011 Oct;33 Suppl 2:S140-5
pubmed: 21952572
Palliat Support Care. 2015 Apr;13(2):295-303
pubmed: 24762215
Soc Sci Med. 2015 Mar;128:52-6
pubmed: 25589032
J Clin Oncol. 2007 Oct 20;25(30):4829-34
pubmed: 17947732
BMJ Support Palliat Care. 2016 Jun;6(2):170-7
pubmed: 24644212
Cancer. 2016 Jul 15;122(14):2251-9
pubmed: 27171617
Soc Sci Med. 1993 Mar;36(5):693-701
pubmed: 8456339
J Pain Symptom Manage. 2015 Mar;49(3):555-61
pubmed: 25116913
Palliat Support Care. 2019 Oct;17(5):590-595
pubmed: 30887936
JAMA. 2016 Jul 5;316(1):79-90
pubmed: 27380345
BMC Palliat Care. 2016 Feb 29;15:24
pubmed: 26924601
Am J Psychiatry. 1995 Aug;152(8):1185-91
pubmed: 7625468
Palliat Med. 2010 Mar;24(2):127-44
pubmed: 20085963
Psychooncology. 2009 May;18(5):490-9
pubmed: 18821528
PLoS One. 2012;7(5):e37117
pubmed: 22606338
J Pain Symptom Manage. 2001 Sep;22(3):717-26
pubmed: 11532585
J Pain Symptom Manage. 2011 Feb;41(2):456-68
pubmed: 20832987
Psychooncology. 2006 Apr;15(4):355-60
pubmed: 16184617
Palliat Med. 2013 Jan;27(1):13-26
pubmed: 23128904
Am J Psychiatry. 1999 Jan;156(1):94-100
pubmed: 9892303
J Pain Symptom Manage. 2015 Jan;49(1):126-34
pubmed: 24878066
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
BMC Palliat Care. 2014 Jul 31;13:38
pubmed: 25161387
Palliat Med. 2006 Oct;20(7):693-701
pubmed: 17060268
J Pain Symptom Manage. 2001 Dec;22(6):1016-26
pubmed: 11738164
Soc Sci Med. 2009 Jul;69(2):165-71
pubmed: 19482401
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
J Clin Oncol. 2018 Aug 10;36(23):2422-2432
pubmed: 29958037
Am J Hosp Palliat Care. 2003 Mar-Apr;20(2):99-104
pubmed: 12693641
Cancer. 2016 Jul 15;122(14):2260-7
pubmed: 27171544
J Pain Symptom Manage. 2015 May;49(5):945-52
pubmed: 25523890
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
J Clin Oncol. 2010 Jun 20;28(18):3084-9
pubmed: 20479397
Cancer Nurs. 2007 Sep-Oct;30(5):405-11
pubmed: 17876187
Eur J Cancer. 2011 Mar;47(4):554-60
pubmed: 21126869
J Med Ethics. 2011 Apr;37(4):205-11
pubmed: 21278132
Soc Sci Med. 2014 Jun;111:35-40
pubmed: 24747154
N Engl J Med. 2017 May 25;376(21):2082-2088
pubmed: 28538128
Aging Ment Health. 2017 Mar;21(3):289-296
pubmed: 26323250
BMJ Support Palliat Care. 2021 Mar;11(1):107-114
pubmed: 30826737
J Psychosom Res. 2014 Mar;76(3):221-6
pubmed: 24529041
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
J Clin Oncol. 1984 Mar;2(3):187-93
pubmed: 6699671
Res Nurs Health. 1992 Aug;15(4):271-83
pubmed: 1386680
PLoS One. 2016 Jan 04;11(1):e0146184
pubmed: 26726801
Soc Sci Med. 2009 Feb;68(3):562-9
pubmed: 19059687
JAMA. 2000 Nov 15;284(19):2460-8
pubmed: 11074775
Palliat Med. 2019 Sep;33(8):1091-1105
pubmed: 31244384
Psychooncology. 2021 May;30(5):716-727
pubmed: 33368836
Psychol Assess. 2017 Mar;29(3):349-353
pubmed: 27280743
Indian J Psychiatry. 2005 Apr;47(2):79-83
pubmed: 20711286
Cancer. 2015 May 1;121(9):1513-9
pubmed: 25677095
JAMA Oncol. 2017 Oct 1;3(10):1403-1406
pubmed: 28384683
J Pain Symptom Manage. 2001 Jul;22(1):544-53
pubmed: 11516596
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
CMAJ. 2020 Feb 24;192(8):E173-E181
pubmed: 32051130
Cancer. 2014 Aug 1;120(15):2247-54
pubmed: 24888335
Palliat Support Care. 2011 Jun;9(2):123-8
pubmed: 24468479
J Pain Symptom Manage. 2018 Mar;55(3):985-991.e1
pubmed: 29155291
BMC Palliat Care. 2018 Jul 23;17(1):96
pubmed: 30037346
Palliat Med. 2005 Mar;19(2):143-50
pubmed: 15810754
Am J Psychiatry. 1983 Jun;140(6):734-9
pubmed: 6846631
Lancet. 2002 Dec 21-28;360(9350):2026-30
pubmed: 12504398
J Oncol Pract. 2016 May;12(5):e513-26
pubmed: 27048610
Patient Educ Couns. 2017 Jul;100(7):1322-1328
pubmed: 28214167
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychooncology. 2011 Aug;20(8):795-804
pubmed: 20821377
J Clin Epidemiol. 2012 Oct;65(10):1107-16
pubmed: 22818947
Psychooncology. 2013 Jul;22(7):1557-64
pubmed: 22941765
Qual Life Res. 2009 Aug;18(6):747-52
pubmed: 19513815
J Pain Symptom Manage. 2007 Jun;33(6):661-75
pubmed: 17531909
Psychol Assess. 2016 Nov;28(11):1379-1391
pubmed: 26653052
BMC Palliat Care. 2018 Feb 20;17(1):30
pubmed: 29458344
Palliat Med. 2005 Sep;19(6):454-60
pubmed: 16218157